ADT is the Building Block for Advanced Prostate Cancer Therapy скачать в хорошем качестве

ADT is the Building Block for Advanced Prostate Cancer Therapy

E. David Crawford, MD, Professor of Urology and Jack A. Vickers Director of Prostate Research at the University of California and Editor-in-Chief at Grand Rounds in Urology, leads a discussion on Androgen Deprivation Therapy (ADT) as the foundation for advanced prostate cancer treatment, supported by Verity Pharmaceuticals. Joining him are Scott B. Selinger, MD, President of the Advanced Urology Institute, Chair of the Advanced Urology Institute’s Advanced Prostate Cancer committee, and President-Elect of the Large Urology Group Practice Association (LUGPA), and David S. Morris, MD, FACS, President and Director of the Advanced Therapeutics Center for Urology Associates.